Modern assessment of lung disease Dr Alex Horsley NIHR Clinician Scientist Senior Lecturer, University of Manchester Honorary Consultant, Manchester Adult.

Slides:



Advertisements
Similar presentations
Body Plethysmography Angela Lorenzo, MS, RRT, RPFT Respiratory Care Division School of Health Science.
Advertisements

Musculoskeletal Imaging Musculoskeletal diseases debilitate millions of people and are tremendous burden on health care systems worldwide. It was estimated.
Capnography Erika A. Gibson, DVM Michigan State University
Respiratory Function Tests RFTs
Sarah Svenningsen University of Western Ontario Medical Biophysics April. 6, 2010.
Pulmonary Function Testing in Cystic Fibrosis
© The Children’s Hospital of Philadelphia. Proprietary and confidential. Do not copy. The Effects of Secondhand Smoke in the Lung - Hyperpolarized.
Respiratory Volumes Used to assess a person’s respiratory status
Wasted Ventilation. Dead Space dead space is the volume of air which is inhaled that does not take part in the gas exchange, either because it (1)
Copyright © 2013, 2009, 2003, 1999, 1995, 1990, 1982, 1977, 1973, 1969 by Mosby, an imprint of Elsevier Inc. Chapter 19 Pulmonary Function Testing.
1 MRI Biomarkers for Cancer Assessment October 14, 2011 Jens Jensen Center for Biomedical Imaging and Department of Radiology.
Multimodal Visualization for neurosurgical planning CMPS 261 June 8 th 2010 Uliana Popov.
RESPIRATION Dr. Zainab H.H Dept. of Physiology Lec.5,6.
Respiratory function tests
Pulmonary function test By Maisa Mansour, MD. PFT PTF is one of the most important and most frequently utilized investigations in our field. Why do.
Respiratory Function Test Department of internal medicine Chen Yu.
The Role of Imaging in Sinusitis Dr Mohamed El Safwany, MD.
Respiratory Function Tests Fiona Gilmour SHO 03/06/04.
1 © 2013 Cengage Learning. All Rights Reserved. May not be copied, scanned, or duplicated, in whole or in part, except for use as permitted in a license.
PULMONARY FUNCTION MEASUREMENTS MODULE D. Objectives At the completion of this module you will: List the four lung volumes including the following information:
Respiratory Function Test Department of internal medicine Chen Yu.
Chapter 16.  Ventilation includes:  Inspiration (inhalation)  Expiration (exhalation)
Identifying Airways Associated with Hyper-Reactivity in Asthma: Interfacing PET imaging and Dynamic Mechanical Function with 3D Airway Models N.T. Tgavalekos.
Developing a National Critical Care Clinical Research Network: what’s in it for trainees? Paul Dark Associate Professor, Faculty of Medical and Human Sciences,
CF Incidence, Prevalence and Survival Carrier rate of 1 in 25 Incidence of 1 in 2,500 live births By 2002 the number.
Measuring Neonatal Lung Volume
Respiratory Function, Breathing, Respiration BI 233 Exercise 40.
Lung Function Tests Normal and abnormal Prof. J. Hanacek, MD, PhD.
Measuring end-expiratory lung volume Giacomo Bellani, M.D., Ph.D. University of Milano-Bicocca Monza, Italy
Normal and abnormal Prof. J. Hanacek, MD, PhD
Pulmonary Function Measurements
Spirometry A. H. Mehrparvar, MD Occupational Medicine department Yazd University of Medical Sciences.
All you need to know about the lungs Dr David Lacy.
Lung Volumes and Capacities
An Overview of Pulmonary Function Tests Norah Khathlan M.D. Consultant Pediatric Intensivist 10/2007.
23-Jan-16lung functions1 Lung Function Tests Ventilatory Functions Gas Exchange.
Pulmonary Function Tests (PFTs)
MECHANICS Of breathing/Tests of lung function
Study – Preliminary data
Respiratory Function Tests RFTs. Review Of Anatomy & physiology Lungs comprised of  Airways  Alveoli.
New Developments in Cystic Fibrosis
Lung Volumes and Capacities The total volume contained in the lung at the end of a maximal inspiration is subdivided into volumes and subdivided into capacities.
Clinical Application of Pulmonary Function Tests Sevda Özdoğan MD, Prof. Chest Diseases.
What your test results mean to you and your doctor Emily Gilbert, MD Assistant Professor, Dept of Medicine Div of Pulmonary & Critical Care Loyola University.
The Spirometry 1 Dr Mazen Qusaibaty MD, DIS / Head Pulmonary and Internist Department Ibnalnafisse Hospital Ministry of Syrian health –
Calculation of conductive inhomogeneity in children with Cystic Fibrosis lung disease: which method works? Verger N2, Arigliani M1, Raywood E3, Duncan.
Respiratory ventilation
CT-based surrogates of pulmonary ventilation in lung cancer:
Effect of dornase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis  Michael W. Konstan, Felix Ratjen 
Take a Deep Breath – Focus on the air- Where is it going?
Brown SMN1,2, Bush A1,2, Davies JC1,2, Thursfield R1,2, Lloyd CM1
Advances in Cystic Fibrosis Views and Perspectives From Basel, Switzerland, 2016.
Volume 150, Issue 6, Pages (December 2016)
Bland–Altman comparison of lung clearance index (LCI) from multiple breath wash-out following open and modified closed circuit wash-in for both healthy.
Nitrogen concentration curve at the end of the washout from a nitrogen multiple-breath washout measurement in a patient with primary ciliary dyskinesia.
Treatment response of airway clearance assessed by single-breath washout in children with cystic fibrosis  Chiara Abbas, Florian Singer, Sophie Yammine,
Use of Elastic Registration in Pulmonary MRI for the Assessment of Pulmonary Fibrosis in Patients with Systemic Sclerosis Areas of marked lung shrinkage.
Change in lung clearance index (LCI) (mean±sd % change lung turnovers compared with baseline) based on modelled a, b) continuous and c, d) isolated pre-capillary.
Use of hyperpolarized helium-3 MRI to assess response to ivacaftor treatment in patients with cystic fibrosis  Talissa A. Altes, Mac Johnson, Meredith.
Calculation of the capnographic index based on expiratory molar mass–volume-curves — A suitable tool to screen for cystic fibrosis lung disease  Susanne.
A) Overview of a nitrogen multiple-breath washout measurement in LungSim (NM GmbH); the crosses represent the end-tidal nitrogen concentration per breath,
Respiratory Function Test
Sophie Yammine, Florian Singer, Per Gustafsson, Philipp Latzin 
Differences in a) functional residual capacity (FRC) and b) lung clearance index (LCI) when using all trials in comparison with only the first two trials.
Receiver operating characteristic ROC curve of Lung Clearance Index (LCI)1/40, LCI1/30, LCI1/20, LCI1/10 and inverse forced expiratory volume in 1 s %
Journal of Cystic Fibrosis
Bland–Altman comparison of functional residual capacity (FRC) measured from multiple breath wash-out following open and modified closed circuit wash-in.
Robert P. Thomen, Laura L. Walkup, David J. Roach, Zackary I
Greg Redding, MD Professor of Pediatrics
Presentation transcript:

Modern assessment of lung disease Dr Alex Horsley NIHR Clinician Scientist Senior Lecturer, University of Manchester Honorary Consultant, Manchester Adult CF Centre

Multiple breath washout Follow the concentration of an inert tracer gas washed from the lungs during tidal breathing – Helium, SF 6 – Nitrogen  washed out by breathing O 2 As airways become diseased, distribution of ventilation in the lungs becomes uneven  Changes how tracer gases are washed out Hyperpolarized Helium MRI scans of CF lungs Mentore et al., Academic Radiology 2005; 12:

Performing a multiple breath washout test Subject Flowmeter Gas Cylinder 0.2% SF 6 in air Gas signal Flow signal Analyser Flowpast circuit Patient lungs Flow SF 6 x3

Assessment of MBW 1. Volume of tracer gas Volume in lungs at start (FRC) 2. Total volume expired to end of washout = CEV LCI = CEV/FRC SF 6 % Flow (L/s) 1/40 th

Lung Clearance Index Cumulative expired volume (required to wash out the tracer to 1/40 of starting concentration) Functional Residual Capacity (= volume of air in lungs at start of washout) = = Number of lung volume turnovers required to wash out the SF 6

Not strictly a modern technique... First described in the 1950’s using Nitrogen as the tracer gas and O 2 to washout

LCI is a sensitive marker of airways disease in children Cystic fibrosis Healthy controls Normal range FEV 1 Elevated LCI 22 CF children 33 healthy control Age 6-16yrs Aurora et al. Thorax 2004; 59(12): 1068

LCI in CF becomes abnormal shortly after birth Postnatal age (weeks) Lung Clearance Index 0100 Cystic fibrosis Healthy controls 1yr old Evidence of airways inflammation in BAL of CF infants Increasing interest in early identification, & aggressive treatment of airways inflammation Lum et al. Thorax 2007; 62: 341

Adults & children, LCI range fixed >20yrs Horsley et al, Thorax 2008 LCI has a narrow range of normal across different populations & ages Children, 3 centres LCI range fixed 6-20yrs Lum et al, ERJ 2013

Key features of LCI More sensitive than FEV 1 – Infants through to adults Repeatable & reproducible User friendly More sensitive to CT changes than spirometry – 85-94% for CT changes vs 19-26% for FEV 1 More sensitive to effects of treatments – HTS – DNase – Ivacaftor – Not IV antibiotics Narrow range of normal, essentially fixed But.... Non-specific More complicated than spirometry

Usefulness of different lung function measurements LCIFEF FEV 1 Lung Function Disease progression

MBW technologies Original studies largely based on mass spec – Not suitable for clinical work Newer N 2 washout systems – No wash-in – Need wall O 2 supply – Results not comparable to SF 6 – ?impact of body N 2 Innocor – Currently undergoing adaptation and refinement – Portable system – Optimised wash-in

Cannot image the soft tissue in the lungs with MRI – Proton signal too low Can use tracer gas with a magnetic signal to image ventilation distribution – Xenon – Helium 3 Needs to be hyperpolarized to enhance the nuclear magnetic signal – Polarized laser light at high temp to align the nuclear spins Helium MRI 3 He MRI 1 H MRI 3 He segmented 3 He MRI 1 H MRI 3 He segmented 3He volume McMahon et al, Eur Radiol 2006

Helium MRI in CF: improvement with Ivacaftor FEV 1 62% 28d Ivacaftor FEV 1 83% 14d placebo FEV 1 72% Altes et al, NACF 2012

Ongoing HeMRI studies in CF Compare LCI and HeMRI in children with CF – Sensitivity of different methods? – Ventilation defects in asymptomatic patients? – Are ventilation defects localised or diffuse? Funded by CF Trust – 20 CF patients to have MRI, LCI, CT and lung function – 10 Healthy controls: MRI, LCI, lung function MRILCI

HeMRI appears to be more sensitive than LCI Preliminary data so far 2 of 4 CF patients with normal LCI All have ventilation defects on MRI Undergoing further analysis to quantify ventilation defects and ventilation efficiency More data to be presented at winter BTS Healthy volunteerPatients with CF

Hugely powerful technique Considerable potential as a research tool and trial endpoint Can also perform dynamic imaging during washout – Quantify time constant of voxels – Produce a washout efficiency map of the lungs – Plan to relate this to LCI But… Very specialised Expensive Hard to get hold of He 3 Helium MRI

Future of lung physiology in CF Move to clinical application of MBW – Milder patients Adoption in clinical trials – EMA considering LCI as primary endpoint for CF trials – Improved technologies that are commercially available – Improved assessment and analysis algorithms HeMRI a powerful and exciting new method of visualising lung function in an entirely new way – Will tell us lots about evolution and resolution of lung disease

Acknowledgements NIHR University of Manchester Manchester Adult CF Centre Prof Jim Wild Dr Helen Marshall Felix Horn Prof Jane Davies Dr Nicholas Bell CF Trust